Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. [electronic resource]
Producer: 20040608Description: 1811-22 p. digitalISSN:- 0066-4804
- Airway Obstruction -- etiology
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Viral -- therapeutic use
- Antiviral Agents -- therapeutic use
- Bronchial Hyperreactivity -- etiology
- Bronchoalveolar Lavage Fluid -- chemistry
- Cell Line
- Chemokines -- metabolism
- Cytokines -- metabolism
- Humans
- Lung -- pathology
- Mice
- Mice, Inbred BALB C
- Palivizumab
- Plethysmography, Whole Body
- Pneumonia -- drug therapy
- Respiratory Function Tests
- Respiratory Syncytial Virus Infections -- complications
- Tissue Fixation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.